Trial results and news from top cornea specialists at the American Academy of Ophthalmology meeting topped cornea-related news in November.Here are the top five most-read cornea articles and most-watched cornea videos on Healio.com/OSN for the month: O…
Author: Healio ophthalmology
Increase in choroidal thickness seen after CPAP therapy
Patients with obstructive sleep apnea syndrome who underwent continuous positive airway pressure therapy experienced an increase in choroidal thickness after 12 months, according to a study.The prospective, observational study included 30 eyes of 30 pa…
Blogs by David Khorram, MD, focus on global ophthalmology
In 2018, Healio.com/OSN introduced a new blogger, David Khorram, MD, who writes about global ophthalmology and issued related to combating global blindness.Catch up with his first four entries here: BLOG: What is global ophthalmology?For the past few d…
Blogs by David Khorram, MD, focus on global ophthalmology
In 2018, Healio.com/OSN introduced a new blogger, David Khorram, MD, who writes about global ophthalmology and issued related to combating global blindness.Catch up with his first four entries here: BLOG: What is global ophthalmology?For the past few d…
OD-OS releases software for iridotomy treatment with Navilas 577s laser
OD-OS has released new software for the Navilas 577s retinal laser system.The version 3.5 software includes an intuitive anterior segment treatment mode for laser peripheral iridotomy for the treatment of narrow-angle glaucoma, a press release said.It …
Catch up with Dr. White’s ‘The Dry Eye’
Darrell E. White, MD, writes a monthly column in Ocular Surgery News discussing issues related to dry eye disease.Catch up with his 2018 articles here: Follow the money, part 1To have any chance whatsoever to offer support to meaningful change in how o…
New technology detects firing of nerve cells
Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of the body, has been created by researchers at Stanford University, according to a press release from the …
Gene therapy fails to show clinical activity in X-linked retinoschisis
An investigational AAV-based gene therapy from Applied Genetic Technologies Corporation for X-linked retinoschisis due to mutations in the RS1 gene showed no signs of clinical activity at 6 months in a phase 1/2 trial, the company announced.The rAAV2tY…
VIDEO: Presbyopia correction: How to choose between EDOF, MTF or mix-and-match IOLs
NEW YORK — From OSN New York 2018, Maria C. Scott, MD, founder of Chesapeake Eye Care and Laser Center in Annapolis, Maryland, gives her presentation on how to choose between extended depth of focus, multifocal and mix-and-match IOLs.
Europe’s Luxturna approval tops November retina news
The European Commission’s approval of Luxturna for inherited retinal disease was the most-read retina-related article on Healio.com/OSN in November. Other top news included clinical trial updates from Clearside and Adverum.Here are the top five most-re…
Aerpio posts quarterly net income
Aerpio Pharmaceuticals reported a net income of $11.5 million, or $0.28 per share, in the third quarter of 2018 compared with a net loss of $4.6 million, or $0.17 per share, in 2017’s third quarter.Revenue was $18.8 million in the quarter compared with…
Quality of life improvements sustained in trial of GenSight’s LHON treatment
GS010 for Leber hereditary optic neuropathy demonstrated quality of life improvements in a phase 3 clinical trial, GenSight Biologics announced in a press release.The phase 3 REVERSE trial evaluated the safety and efficacy of a single intravitreal inje…
VIDEO: Nuclear disassembly: The new divide and conquer
NEW YORK — From OSN New York 2018, Jennifer Loh, MD, of Loh Ophthalmology Associates of Miami, gives her presentation on the miLOOP (IanTECH/Zeiss) for nuclear disassembly.
Anthem Blue Cross Blue Shield to cover Avedro’s corneal cross-linking
Anthem Blue Cross Blue Shield will cover Avedro’s Photrexa formulations and KXL System for corneal cross-linking, the company announced in a press release.This brings the number of commercial payers covering the procedure to 60, including the U.S.’s la…
AAO: Keep safety standards high in scope-of-practice expansions
The American Academy of Ophthalmology agrees with a joint federal report’s recommendations on scope of practice, the organization announced in a press release.The report, issued by the U.S. Department of Health and Human Services, the U.S. Department o…
Mazzo named OCTANe board chairman
OCTANe has appointed Jim Mazzo as the chairman of its board of directors, according to a press release.Mazzo, global president of ophthalmic devices at Carl Zeiss Meditec, will take over the 2-year term as of Jan. 1, 2019.“Jim has been a strong advocat…
How US-Canada-Mexico trade deal could impact drug prices, research
The United States-Mexico-Canada Agreement keeps biologic drug prices high but could potentially spur new research opportunities, a pharmaceutical expert told Healio Family Medicine.The agreement between the three countries announced on Nov. 30, but sti…
FDA approves Alembic’s allergic conjunctivitis treatment
The FDA has approved an abbreviated new drug application for olopatadine hydrochloride ophthalmic solution 0.1%, Alembic Pharmaceuticals announced in a press release.The solution is therapeutically equivalent to Patanol ophthalmic solution 0.1% (Novart…
Verkazia approved in Scotland for vernal keratoconjunctivitis in children, adolescents
The Scottish Medicines Consortium has approved Verkazia eye drop emulsion for the treatment of vernal keratoconjunctivitis in children from 4 years of age and adolescents, Santen UK Limited announced in a press release.Verkazia, which contains 0.1% cyc…
Akorn loses Fresenius appeal; CEO to step down
The Delaware Supreme Court upheld a lower court decision allowing Fresenius Kabi to back out of a $4.3 billion acquisition of Akorn, prompting Akorn CEO Raj Rai to step down, according to a press release.Akorn will begin a formal search for a new CEO a…